ResourcesStretching Scarce Authorizing Legislation as Far as Possible: A Legislative History of the 340B Drug Pricing Program Resources / healnetwork1
Op-Ed, ResourcesOp-ed at The Well News: The 340B Windfall That Misses Patients Op-Ed, Resources / healnetwork1
ResourcesThe Forgotten Opportunity: Improving Traditional Medicare Operations Resources / healnetwork1
ResourcesWhen Safety-Net Programs Compete: Medicaid, 340B, And the Battle Over Drug Discounts Resources / healnetwork1
ResourcesFinancial Outcomes and Community Benefit in the 340B Program: Comparing 340B and Non-340B Hospitals Resources / healnetwork1
ResourcesWhen Lower Prices Don’t Mean Lower Costs: How Part D Benefit Changes Are Shifting Out-of-Pocket Spending in 2026 Under the Inflation Reduction Act Resources / healnetwork1
ResourcesIncreasing Payer Control for Medicare Patients Initiating Branded Medicines Resources / healnetwork1
ResourcesThe Impact of Intellectual Property Protection on Post-Approval Innovation Resources / healnetwork1
